Antidepressants a Concern in Young Patients.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read Online Read More Add to Saved list
  • Source:
    Nutrition Health Review: The Consumer's Medical Journal. 2003, Issue 88, p14-14. 1/6p.
  • Additional Information
    • Subject Terms:
      ANTIDEPRESSANTS; PATIENTS; MENTAL depression; CLINICAL trials; MEDICAL research; GLAXOSMITHKLINE
    • Abstract:
      Health authorities have warned patients taking antidepressants, including children and teenagers, that signs of worsening depression and suicidal thoughts should be monitored. The warning comes after a panel of experts in February 2004 called on the U.S. FDA to issue stronger warnings to patients taking antidepressants. Health officials have not yet reached a final conclusion about the drugs safety, but studies continue. GlaxoSmithKline PLC's antidepressant, paroxetine, raised safety concerns after regulators reviewed its clinical trials. The FDA has advised patients and doctors to be more aware of signs of hostility, anxiety, insomnia, and other depression-related thoughts.